Cargando…

Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics

Partial solvation parameters (PSP) have much in common with the Hansen solubility parameter or with a linear solvation energy relationship (LSER), but there are advantages based on the sound thermodynamic basis. It is, therefore, surprising that PSP has so far not been harnessed in pharmaceutics for...

Descripción completa

Detalles Bibliográficos
Autores principales: Niederquell, Andreas, Wyttenbach, Nicole, Kuentz, Martin, Panayiotou, Costas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359455/
https://www.ncbi.nlm.nih.gov/pubmed/30621192
http://dx.doi.org/10.3390/pharmaceutics11010017
_version_ 1783392256188743680
author Niederquell, Andreas
Wyttenbach, Nicole
Kuentz, Martin
Panayiotou, Costas
author_facet Niederquell, Andreas
Wyttenbach, Nicole
Kuentz, Martin
Panayiotou, Costas
author_sort Niederquell, Andreas
collection PubMed
description Partial solvation parameters (PSP) have much in common with the Hansen solubility parameter or with a linear solvation energy relationship (LSER), but there are advantages based on the sound thermodynamic basis. It is, therefore, surprising that PSP has so far not been harnessed in pharmaceutics for the selection of excipients or property estimation of formulations and their components. This work introduces PSP calculation for drugs, where the raw data were obtained from inverse gas chromatography. It was shown that only a few probe gases were needed to get reasonable estimates of the drug PSPs. Interestingly, an alternative calculation of LSER parameters in silico did not reflect the experimentally obtained activity coefficients for all probe gases as well, which was attributed to the complexity of the drug structures. The experimental PSPs were proven to be helpful in predicting drug solubility in various solvents and the PSP framework allowed calculation of the different surface energy contributions. A specific benefit of PSP is that parameters can be readily converted to either classical solubility or LSER parameters. Therefore, PSP is not just about a new definition of solvatochromic parameters, but the underlying thermodynamics provides a unified approach, which holds much promise for broad applications in pharmaceutics.
format Online
Article
Text
id pubmed-6359455
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63594552019-02-14 Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics Niederquell, Andreas Wyttenbach, Nicole Kuentz, Martin Panayiotou, Costas Pharmaceutics Article Partial solvation parameters (PSP) have much in common with the Hansen solubility parameter or with a linear solvation energy relationship (LSER), but there are advantages based on the sound thermodynamic basis. It is, therefore, surprising that PSP has so far not been harnessed in pharmaceutics for the selection of excipients or property estimation of formulations and their components. This work introduces PSP calculation for drugs, where the raw data were obtained from inverse gas chromatography. It was shown that only a few probe gases were needed to get reasonable estimates of the drug PSPs. Interestingly, an alternative calculation of LSER parameters in silico did not reflect the experimentally obtained activity coefficients for all probe gases as well, which was attributed to the complexity of the drug structures. The experimental PSPs were proven to be helpful in predicting drug solubility in various solvents and the PSP framework allowed calculation of the different surface energy contributions. A specific benefit of PSP is that parameters can be readily converted to either classical solubility or LSER parameters. Therefore, PSP is not just about a new definition of solvatochromic parameters, but the underlying thermodynamics provides a unified approach, which holds much promise for broad applications in pharmaceutics. MDPI 2019-01-04 /pmc/articles/PMC6359455/ /pubmed/30621192 http://dx.doi.org/10.3390/pharmaceutics11010017 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Niederquell, Andreas
Wyttenbach, Nicole
Kuentz, Martin
Panayiotou, Costas
Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics
title Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics
title_full Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics
title_fullStr Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics
title_full_unstemmed Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics
title_short Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics
title_sort partial solvation parameters of drugs as a new thermodynamic tool for pharmaceutics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359455/
https://www.ncbi.nlm.nih.gov/pubmed/30621192
http://dx.doi.org/10.3390/pharmaceutics11010017
work_keys_str_mv AT niederquellandreas partialsolvationparametersofdrugsasanewthermodynamictoolforpharmaceutics
AT wyttenbachnicole partialsolvationparametersofdrugsasanewthermodynamictoolforpharmaceutics
AT kuentzmartin partialsolvationparametersofdrugsasanewthermodynamictoolforpharmaceutics
AT panayiotoucostas partialsolvationparametersofdrugsasanewthermodynamictoolforpharmaceutics